Clinicopathological analysis of epithelioid inflammatory myofibroblastic sarcoma.

about

Clinicopathological analysis of epithelioid inflammatory myofibroblastic sarcoma.

Item

http://www.wikidata.org/entity/Q54977985

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Clinicopathological analysis of epithelioid inflammatory myofibroblastic sarcoma.

@en

Clinicopathological analysis of epithelioid inflammatory myofibroblastic sarcoma.

@nl

type

Item

label

Clinicopathological analysis of epithelioid inflammatory myofibroblastic sarcoma.

@en

Clinicopathological analysis of epithelioid inflammatory myofibroblastic sarcoma.

@nl

prefLabel

Clinicopathological analysis of epithelioid inflammatory myofibroblastic sarcoma.

@en

Clinicopathological analysis of epithelioid inflammatory myofibroblastic sarcoma.

@nl

P1476

Clinicopathological analysis of epithelioid inflammatory myofibroblastic sarcoma.

@en

P2093

Bin Li

http://www.w3.org/2001/XMLSchema#string

Daye Wang

http://www.w3.org/2001/XMLSchema#string

Hongyu Zhao

http://www.w3.org/2001/XMLSchema#string

Weimin Xue

http://www.w3.org/2001/XMLSchema#string

Xuemei Du

http://www.w3.org/2001/XMLSchema#string

Ying Gao

http://www.w3.org/2001/XMLSchema#string

P2860

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Current status and perspectives in translational biomarker research for PD-1/PD-L1 immune checkpoint blockade therapy

Pulmonary epithelioid inflammatory myofibroblastic sarcoma with multiple bone metastases: case report and review of literature

Epithelioid inflammatory myofibroblastic sarcoma treated with ALK inhibitor: a case report and review of literature

Expression of programmed death ligand 1 (PD-L1) is associated with poor prognosis in human breast cancer

Phase I safety and pharmacokinetic study of CT-011, a humanized antibody interacting with PD-1, in patients with advanced hematologic malignancies.

Inflammatory myofibroblastic tumours: where are we now?

Epithelioid inflammatory myofibroblastic sarcoma in abdominal cavity: a case report and review of literature.

Epithelioid inflammatory myofibroblastic sarcoma with recurrence after extensive resection: significant clinicopathologic characteristics of a rare aggressive soft tissue neoplasm

Assessment of tumoral PD-L1 expression and intratumoral CD8+ T cells in urothelial carcinoma.

P304

9317-9326

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2018.8530

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-04-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29805657

http://www.w3.org/2001/XMLSchema#string

P921

epithelioid inflammatory myofibroblastic sarcoma

P932

5958778

http://www.w3.org/2001/XMLSchema#string